Cargando…
The emerging potential of siRNA nanotherapeutics in treatment of arthritis
RNA interference (RNAi) using small interfering RNA (siRNA) has shown potential as a therapeutic option for the treatment of arthritis by silencing specific genes. However, siRNA delivery faces several challenges, including stability, targeting, off-target effects, endosomal escape, immune response...
Autores principales: | Kumari, Anjali, Kaur, Amanpreet, Aggarwal, Geeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594572/ https://www.ncbi.nlm.nih.gov/pubmed/37881798 http://dx.doi.org/10.1016/j.ajps.2023.100845 |
Ejemplares similares
-
Peptide-siRNA nanotherapeutics in arthritis
por: Pham, Christine T.N., et al.
Publicado: (2015) -
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021) -
Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019) -
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
por: Sargazi, Saman, et al.
Publicado: (2022) -
Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA
por: Mahajan, Supriya D., et al.
Publicado: (2011)